Preventive potential of vaccination against herpes zoster on cardiovascular event risk
Cardiovascular Risk and Diseases
ESC 2025
Related content
RECOMMENDED
Cardiovascular Risk and Diseases
Adjudicated Cardiovascular Events in Patients With COVID-19: Association With Vaccination Status and Changes over Time
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
J Am Heart Assoc
Bikdeli B, Krishnathasan D, Bejjani A, Khairani CD, Hamade N, Campia U, Davies J, Porio N, Assi A, Armero A, Tristani A, Ortiz-Rios MD, Nauffal V, Almarzooq ZI, Wei EQ, McGonagle B, Pfeferman M, Rashedi S, Sato A, Scimeca G, Zuluaga-Sánchez V, Zarghami M, Achanta A, Jesudasen S, Tiu BC, Merli GJ, Leiva O, Fanikos J, Sharma AM, Rizzo SM, Morrison RB, Vishnevsky A, Rao SJ, Naveh S, El Rafei A, Welker J, Bonaca MP, Carroll BJ, Goldhaber SZ, Lan Z, Piazza G, CORONA‐VTE Network Investigators
doi: 10.1161/JAHA.125.044011
Cardiovascular Risk and Diseases
AHA PREVENT Equations and Lipoprotein(a) for Cardiovascular Disease Risk : Insights From MESA and the UK Biobank
JAMA Cardiol
Bhatia HS, Ambrosio M, Razavi AC, Alebna PL, Yeang C, Spitz JA, Patel J, Tsai MY, Sperling L, Shapiro MD, Tsimikas S, Mehta A
doi: 10.1001/jamacardio.2025.1603
RECOMMENDED
Further Publications
Blood Pressure Variability and Risk of Cardiovascular Events and Mortality in Real-World Clinical Settings
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
J Am Heart Assoc
Li HL, Lin HJ, Muo CH, Lu CY, Kuo CC, Chen PC
doi: 10.1161/JAHA.124.037658
COMMENTED
Cardiovascular Risk and Diseases
Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Patsoukaki V, Lind L, Lampa E, Radhi S, Eeg-Olofsson K, Eliasson B, Eriksson JW
doi: 10.1016/S2213-8587(25)00165-2
RECOMMENDED
Cardiovascular Risk and Diseases
Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
JAMA Cardiol
Lassen MCH, Ostrominski JW, Claggett BL, Wijkman MO, Lee J, Van't Hof JR, Shah AM, Biering-Sørensen T, Solomon SD, Brown JM, Vaduganathan M
doi: 10.1001/jamacardio.2026.0068
COMMENTED
Cardiovascular Risk and Diseases
Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Vazquez Arreola E, Gong Q, Hanson RL, Wang J, Sandforth L, He S, Sandforth A, Qian X, Giacca M, Bornstein SR, Fritsche A, Stefan N, Preissl H, Gregg EW, Marx N, Jumpertz-von Schwartzenberg R, Li G, Birkenfeld AL
doi: 10.1016/S2213-8587(25)00295-5
COMMENTED
Heart, Artery and Coronary Diseases
Heterogeneity of Cardiovascular Effects of Second-Line Glucose-Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
J Am Heart Assoc
Deng Y, Polley EC, Herrin J, Swarna KS, Kent DM, Ross JS, Maron BA, Mickelson MM, McCoy RG
doi: 10.1161/JAHA.124.040217
Cardiovascular Risk and Diseases
The effectiveness of lifestyle interventions in reducing cardiovascular risk and risk factors in people with prediabetes: A systematic review and meta-analysis
Nutr Metab Cardiovasc Dis
Demissie GD, Birungi J, Shrestha A, Haregu T, Thirunavukkarasu S, Oldenburg B
doi: 10.1016/j.numecd.2025.104130
Cardiovascular Risk and Diseases
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial
JAMA Cardiol
Mulvagh SL, Inzucchi SE, Marx N, Poulter NR, Deanfield JE, Pop-Busui R, Emerson SS, Mann JFE, Engelmann MDM, Hovingh GK, Mandavya K, Davicevic-Elez Z, Jeppesen OK, Lorenzatti A, Oguz A, Mankovsky B, Deerochanawong C, Gorgojo-Martinez JJ, Ji L, Bain SC, McGuire DK, Buse JB, SOUL Study Group
doi: 10.1001/jamacardio.2026.0245